Krüppel-like factor 4 downregulation during esophageal cancer formation facilitates immune evasion and impairs immunotherapy.
Low levels of a specific protein predict immunotherapy failure across multiple cancer types, offering a potential biomarker for treatment selection.
Impaired antigen processing and presentation are critical for cancer immune evasion, but the underlying mechanism is not fully known. Extending beyond esophageal cancer, we reveal that low KLF4 levels are significantly correlated with high immunotherapy failure rates across multiple human cancer types.
What the study was
- Study design
- Animal model study
- Population
- cancer patients
- Category
- Treatment Innovation
- Maturity
- Exploratory
- Journal
- Signal transduction and targeted therapy
Why it surfaced
Score 6/10 [PROMISING_PRELIMINARY]: Animal model study (Journal Article) matched 'Novel therapeutics: immunotherapy, CAR-T'. Components — novelty:2/3, relevance:2/3, design:1/2, population:1/2. Confidence: high. Conservative scoring applied per v1.3 rubric.
A plain-language summary of published research — not medical advice. Talk to a clinician about your own care.